Perkin-Elmer, Dr. J. Craig Venter, And TIGR Announce Formation Of New Genomics Company

ite continued, "We see our exciting new sequencing technology as the catalyst for this new genomics initiative - allowing us to take another step in the redefinition of Perkin-Elmer. When combined with the talents and resources of Dr. Venter and other TIGR scientists who would be employed by the new company, we believe we have the ability to quickly and cost-effectively sequence whole genomes. Together, we intend to build a new business that satisfies the rapidly growing need for genomic information and gene discovery."

Since the inception of the Human Genome Project (HGP) in 1990, a major shift in technology has been anticipated that would allow the entire sequence to be completed. To date, scientists have constructed detailed genetic and physical maps and sequenced approximately three percent of the three billion base pairs of DNA that comprise the human genome and contain the inherited instructions for human development and function.

"The Human Genome Project has been a technology-driven quest," said Dr. Michael W. Hunkapiller, senior vice president of Perkin-Elmer and president of its Applied Biosystems Division. "We're near the end of our technology development phase and about to implement a new sequencing strategy. We believe we can provide the anticipated advance that greatly expedites the sequencing phase of the entire human genome."

The new company plans to make sequencing data publicly available to ensure that as many researchers as possible are examining it and that applications, such as the development of diagnostic tests and new drug discovery, are as broad as possible.

Commenting on the proposed new venture, J. Craig Venter, Ph.D., TIGR's president and director, said, "By linking techniques that have been used by TIGR scientists with Perkin-Elmer's genetic analysis technologies, we pave the way for a new era of post-genomic discovery. The sooner researchers can access the information contained in the complete human genome, t

Contact: Timothy Sipols
212-696-4455 ext.272
Noonan/Russo Communications

Page: 1 2 3 4

Related biology news :

1. Biotechnology Study Center Honors J. Craig Venter, Leonard Bell, and Steven Shak
2. Q & A with Dr. J Craig Venter, July 20th
3. Press availability: J. Craig Venter, Genome Project Chief, available for media inquiries
4. Announcement of the chicken genome sequence and genome variation maps
5. UV Rays, Fire And Flame Retardants To Be Reviewed For Possible Listing As Carcinogens, NTP Announces
6. American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List
7. Science Announces Top Ten Research Advances Of 1998
8. AAAS Announces The Winners Of Its Science Journalism Awards
9. Researchers Announce Breakthrough In Transgenic Animal Technology
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Discovery Of Possible New Weight Control Role For Leptin Announced By Yale University School Of Medicine Researchers

Post Your Comments:

(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: